Queen's University Belfast research could see exercise as a prescribed medicine

Press/Media: Expert Comment

Description

Queen's University Belfast are taking part in a global trial to test whether exercise should be prescribed to treat patients with advanced prostate cancer.

The Global Action Plan 4 Global Prostate Cancer (GAP4) will bring together 150 researchers around the world to share their expertise to improve the life chances of prostate cancer patients and is led by The Movember Foundation.

Dr Suneil Jain from Queen's University added: "This is very exciting research. Many standard treatments cause side-effects including weight gain and loss of muscle bulk. High intensity interval training may make men fitter, improve their quality of life and even prolong their survival. This study is the largest of its kind ever to be performed in prostate cancer."

Period02 Nov 2017

Media contributions

1

Media contributions

  • TitleQueen's University Belfast research could see exercise as a prescribed medicine
    Degree of recognitionInternational
    Media name/outletEurekalert
    Media typeWeb
    CountryUnited Kingdom
    Date02/11/2017
    DescriptionQueen's University Belfast are taking part in a global trial to test whether exercise should be prescribed to treat patients with advanced prostate cancer.

    Dr Suneil Jain from Queen's University added: "This is very exciting research. Many standard treatments cause side-effects including weight gain and loss of muscle bulk. High intensity interval training may make men fitter, improve their quality of life and even prolong their survival. This study is the largest of its kind ever to be performed in prostate cancer."
    URLhttps://www.eurekalert.org/pub_releases/2017-11/qub-qub110217.php
    PersonsSuneil Jain